Thibault Boutherin

Stock Analyst at Morgan Stanley

(1.56)
# 3,015
Out of 5,040 analysts
4
Total ratings
50%
Success rate
0.51%
Average return

Stocks Rated by Thibault Boutherin

Alvotech
Oct 14, 2025
Upgrades: Overweight
Price Target: $14
Current: $8.12
Upside: +72.41%
Novo Nordisk
Sep 29, 2025
Downgrades: Underweight
Price Target: $59$47
Current: $53.21
Upside: -11.67%
Teva Pharmaceutical Industries
May 25, 2023
Initiates: Equal-Weight
Price Target: $10
Current: $19.06
Upside: -47.53%